Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Developmental Cell|August 17, 2010
Tuning mTORC1 activity for balanced self-renewal and differentiationLarissa S Carnevalli, Andreas TrumppFrontiers in Immunology|May 6, 2021
Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor MicroenvironmentLarissa S Carnevalli, Hormas Ghadially, Simon T BarryThe Biochemical Journal|July 26, 2002
Translation initiation at non-AUG codons mediated by weakened association of eukaryotic initiation factor (eIF) 2 subunitsNilce N Hashimoto, Larissa S Carnevalli, Beatriz A CastilhoNature Communications|November 23, 2024
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancerSamar Elorbany, Chiara Berlato, Larissa S Carnevalli, et al.Neuroscience Letters|March 9, 2004
Phosphorylation of translation initiation factor eIF2alpha in the brain during pilocarpine-induced status epilepticus in miceLarissa S Carnevalli, Cátia M Pereira, Beatriz M Longo, et al.Oncotarget|May 17, 2018
Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancerAlvaro Avivar-Valderas, Robert McEwen, Amir Taheri-Ghahfarokhi, et al.Developmental Cell|May 25, 2010
S6K1 plays a critical role in early adipocyte differentiationLarissa S Carnevalli, Kouhei Masuda, Francesca Frigerio, et al.Oncoimmunology|September 18, 2018
Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunitySophie Langdon, Adina Hughes, Molly A Taylor, et al.The Biochemical Journal|February 24, 2006
Phosphorylation of the alpha subunit of translation initiation factor-2 by PKR mediates protein synthesis inhibition in the mouse brain during status epilepticusLarissa S Carnevalli, Catia M Pereira, Carolina B Jaqueta, et al.Ebiomedicine|May 28, 2021
Quantifying cell cycle-dependent drug sensitivities in cancer using a high throughput synchronisation and screening approachTimothy I Johnson, Christopher J Minteer, Daniel Kottmann, et al.Pageof 3